Innovative immune checkpoint modulators: monoclonal antibodies, small molecules, non-coding RNAs, and nanoparticles in cancer immunotherapy
{{output}}
Targeting immune checkpoints through diverse therapeutic platforms has emerged as a promising strategy for cancer immunotherapy, offering improved outcomes compared with conventional chemotherapy. Immune checkpoint pathways are critical regulators in maintaini... ...